These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 29420469)

  • 1. Dopamine neuron activity before action initiation gates and invigorates future movements.
    da Silva JA; Tecuapetla F; Paixão V; Costa RM
    Nature; 2018 Feb; 554(7691):244-248. PubMed ID: 29420469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine neuron activity encodes the length of upcoming contralateral movement sequences.
    Mendonça MD; da Silva JA; Hernandez LF; Castela I; Obeso J; Costa RM
    Curr Biol; 2024 Mar; 34(5):1034-1047.e4. PubMed ID: 38377999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic reduction of mitochondrial complex I function does not lead to loss of dopamine neurons in vivo.
    Kim HW; Choi WS; Sorscher N; Park HJ; Tronche F; Palmiter RD; Xia Z
    Neurobiol Aging; 2015 Sep; 36(9):2617-27. PubMed ID: 26070241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slowly evolving dopaminergic activity modulates the moment-to-moment probability of reward-related self-timed movements.
    Hamilos AE; Spedicato G; Hong Y; Sun F; Li Y; Assad JA
    Elife; 2021 Dec; 10():. PubMed ID: 34939925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
    Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
    Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conditional deletion of Ndufs4 in dopaminergic neurons promotes Parkinson's disease-like non-motor symptoms without loss of dopamine neurons.
    Choi WS; Kim HW; Tronche F; Palmiter RD; Storm DR; Xia Z
    Sci Rep; 2017 Mar; 7():44989. PubMed ID: 28327638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine Inhibition Differentially Controls Excitability of Substantia Nigra Dopamine Neuron Subpopulations through T-Type Calcium Channels.
    Evans RC; Zhu M; Khaliq ZM
    J Neurosci; 2017 Mar; 37(13):3704-3720. PubMed ID: 28264982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implication of regional selectivity of dopamine deficits in impaired suppressing of involuntary movements in Parkinson's disease.
    Lee H; Kim HF; Hikosaka O
    Neurosci Biobehav Rev; 2024 Jul; 162():105719. PubMed ID: 38759470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of dopamine in the brain - lessons learned from Parkinson's disease.
    Meder D; Herz DM; Rowe JB; Lehéricy S; Siebner HR
    Neuroimage; 2019 Apr; 190():79-93. PubMed ID: 30465864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ghrelin on the motor deficit caused by the ablation of nigrostriatal dopaminergic cells or the inhibition of striatal dopamine receptors.
    Suda Y; Kuzumaki N; Narita M; Hamada Y; Shibasaki M; Tanaka K; Tamura H; Kawamura T; Kondo T; Yamanaka A; Narita M
    Biochem Biophys Res Commun; 2018 Feb; 496(4):1102-1108. PubMed ID: 29378186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of ghrelin receptors on dopaminergic neurons in the substantia nigra contributes to Parkinson's disease-like motor dysfunction.
    Suda Y; Kuzumaki N; Sone T; Narita M; Tanaka K; Hamada Y; Iwasawa C; Shibasaki M; Maekawa A; Matsuo M; Akamatsu W; Hattori N; Okano H; Narita M
    Mol Brain; 2018 Feb; 11(1):6. PubMed ID: 29458391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic Neurons and Brain Reward Pathways: From Neurogenesis to Circuit Assembly.
    Luo SX; Huang EJ
    Am J Pathol; 2016 Mar; 186(3):478-88. PubMed ID: 26724386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cerebellum directly modulates the substantia nigra dopaminergic activity.
    Washburn S; Oñate M; Yoshida J; Vera J; Bhuvanasundaram R; Khatami L; Nadim F; Khodakhah K
    Nat Neurosci; 2024 Mar; 27(3):497-513. PubMed ID: 38272967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basal ganglia mechanisms of reward-oriented eye movement.
    Hikosaka O
    Ann N Y Acad Sci; 2007 May; 1104():229-49. PubMed ID: 17360800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional Rescue of Dopaminergic Neuron Loss in Parkinson's Disease Mice After Transplantation of Hematopoietic Stem and Progenitor Cells.
    Altarche-Xifro W; di Vicino U; Muñoz-Martin MI; Bortolozzi A; Bové J; Vila M; Cosma MP
    EBioMedicine; 2016 Jun; 8():83-95. PubMed ID: 27428421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of substantia nigra pars reticulata neurons during smooth pursuit eye movements in monkeys.
    Basso MA; Pokorny JJ; Liu P
    Eur J Neurosci; 2005 Jul; 22(2):448-64. PubMed ID: 16045498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pitx3 deficiency produces decreased dopamine signaling and induces motor deficits in Pitx3(-/-) mice.
    Le W; Zhang L; Xie W; Li S; Dani JA
    Neurobiol Aging; 2015 Dec; 36(12):3314-3320. PubMed ID: 26363812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electroacupuncture Promotes Recovery of Motor Function and Reduces Dopaminergic Neuron Degeneration in Rodent Models of Parkinson's Disease.
    Lin JG; Chen CJ; Yang HB; Chen YH; Hung SY
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diverse midbrain dopaminergic neuron subtypes and implications for complex clinical symptoms of Parkinson's disease.
    Carmichael K; Sullivan B; Lopez E; Sun L; Cai H
    Ageing Neurodegener Dis; 2021; 1(4):. PubMed ID: 34532720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.